Morphine Market Analysis

  • Report ID: 3602
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Morphine Market Analysis

Morphine Segmentation

Application (Pain Management, Diarrhea Suppressant)

In application segmentation, the pain management segment is predicted to dominate the morphine market with a share of 69 percent by the end of 2037. If the patient's pain cannot be managed with regular pain relievers, then the patient is prescribed morphine sustained-release tablets to relieve severe pain. Opioids play an important role in ensuring adequate analgesia in acute postoperative situations. The presence of ailments such as cancer, and other diseases has increased the demand for morphine in ​​pain management. In a study, it was reported that almost 20% of doctors prescribe opioids such as morphine to patients admitted to the emergency ward.

Mode of Administration (Injection, Oral)

In terms of mode of administration, the oral segment in the morphine market is expected to observe the highest CAGR during the time period between 2025- 2037. The oral segment includes morphine in oral tablet and pharmaceutical form. The immediate effect of the oral tablets is within 30 to 60 minutes due to which it is mostly opted by the patients. Moreover, oral morphine provides short as well as long-term severe pain through the capsule and extended-release tablet. Also, it is considered one of the easiest ways that can be taken by the patients themselves.

Our in-depth analysis of the global morphine market includes the following segments:

          Application

  • Pain Management
  •  Diarrhea Suppressant

         Mode of Administration

  • Injection
  • Oral
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3602
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of morphine is assessed at USD 18.2 billion.

The morphine market size was over USD 17.27 billion in 2024 and is projected to reach USD 40.13 billion by 2037, growing at around 6.7% CAGR during the forecast period i.e., between 2025-2037. The growing application of medical morphine as a pain killer is estimated to boost market growth.

North America industry is predicted to dominate majority revenue share of 35% by 2037, due to increasing patient pool of osteoporosis in the region.

The major players in the market include Verve Health Care Ltd., Mayne Pharma Group, Daiichi Sankyo Company Limited, Hikma Pharmaceuticals USA, AbbVie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Alcaliber S.A., Mallinckrodt Pharmaceuticals, AstraZeneca plc
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample